menu
    • menu

    Company profile for Factor Bioscience

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Factor Bioscience was established to explore new methods for controlling gene expression and cell fate. Our scientists developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state, a key invention now recognized by several patents. This technology, which enables the production of patient-specific cells for transplantation, has wide-ranging applications in personalized regene...
    Factor Bioscience was established to explore new methods for controlling gene expression and cell fate. Our scientists developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state, a key invention now recognized by several patents. This technology, which enables the production of patient-specific cells for transplantation, has wide-ranging applications in personalized regenerative medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Factor BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1035 Cambridge St., Suite 17B, Cambridge, MA, 02141
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://factor.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/factorbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tempest Sets Record Date For Warrant Dividend Distribution
    Tempest Sets Record Date For Warrant Dividend Distribution

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3222341/0/en/Tempest-Announces-Record-Date-for-Anticipated-Dividend-Distribution-of-Warrants-to-Stockholders.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Lineage Receives Hypoimmune Gene-Edited Cell Line From Factor Bio
    Lineage Receives Hypoimmune Gene-Edited Cell Line From Factor Bio

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106778477/en/Lineage-Takes-Delivery-of-Gene-edited-Hypoimmune-Cell-Line-Under-Partnership-With-Factor-Bioscience

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Tempest Acquires Factor's Dual-Car T Programs, Extends Runway
    Tempest Acquires Factor's Dual-Car T Programs, Extends Runway

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191025/0/en/Tempest-Announces-Strategic-Acquisition-of-New-Dual-CAR-T-Programs-from-Factor-with-Simultaneous-Runway-Extension-Projected-to-Mid-2027.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Factor Bio Files Complaint Against Cellectis & AstraZeneca
    Factor Bio Files Complaint Against Cellectis & AstraZeneca

    26 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/factor-bioscience-files-complaint-against-cellectis-and-astrazeneca-alleging-infringement-of-foundational-gene-editing-patents-302568302.html

    PR NEWSWIRE
    26 Sep 2025
    Share Share
    Factor Bioscience to Present iMacrophages for Tumors
    Factor Bioscience to Present iMacrophages for Tumors

    10 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/factor-bioscience-to-unveil-imacrophages-engineered-to-combat-solid-tumors-at-the-isscr-annual-meeting-302477389.html

    PR NEWSWIRE
    10 Jun 2025
    Share Share
    Eterna And Factor Bioscience Announce Cell Therapy Collaboration
    Eterna And Factor Bioscience Announce Cell Therapy Collaboration

    17 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/17/2964799/0/en/Eterna-Therapeutics-and-Factor-Bioscience-Announce-Exclusive-License-and-Collaboration-Agreement-to-Accelerate-Cell-Therapy-Development-for-Oncology-Autoimmune-and-Rare-Diseases.html

    GLOBENEWSWIRE
    17 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search